Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
157 hedge funds and large institutions have $542M invested in Immunogen Inc in 2017 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 42 increasing their positions, 46 reducing their positions, and 9 closing their positions.
256% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 9
155% more call options, than puts
Call options by funds: $4.33M | Put options by funds: $1.7M
107% more capital invested
Capital invested by funds: $262M → $542M (+$280M)
16% more funds holding
Funds holding: 135 → 157 (+22)
9% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 46
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$22M |
| 2 |
Millennium Management
New York
|
+$13.4M |
| 3 |
State Street
Boston,
Massachusetts
|
+$11.6M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$5.62M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$2.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$9.87M |
| 2 |
ClearBridge Investments
New York
|
-$7.13M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$5.48M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.65M |
| 5 |
Renaissance Technologies
New York
|
-$3.46M |
IMGN Hedge Fund Activity: Q2 2017 in Review
157 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2017, worth a combined $542M — up 107% from $262M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new IMGN positions and 9 closed out — a net gain of 23 holders — while 42 added to existing stakes and 46 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $22M. The largest seller was OrbiMed, cutting an estimated $9.87M.
- 157 institutional investors held Immunogen Inc (IMGN) as of Q2 2017, up from 135 in Q1 2017.
- Funds reported $542M of Immunogen Inc stock for Q2 2017, up 107% quarter-over-quarter.
- 32 funds opened new Immunogen Inc positions in Q2 2017 and 9 closed out, a net change of +23 holders.
- The largest Immunogen Inc buyer in Q2 2017 was Fidelity Investments, an estimated $22M added.
- The largest Immunogen Inc seller in Q2 2017 was OrbiMed, an estimated $9.87M sold.
Based on aggregated 13F filings for Q2 2017.